Business
Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building
Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building.
About this update from Adia Nutrition, Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building\r\n \r\n \r\n\r\n\r\nTonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building\r\n\r\n\r\n\r\nNewsfile Corp.\r\n\r\n\r\nNewsfile Corp\r\n\r\n\r\nWinter Park, Florida--(Newsfile Corp. - March 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med division, is excited to announce a special virtual Zoom presentation happening tonight, Tuesday, March 24, 2026, at 6:00 PM EDT, with the Center for Autism and Related Disabilities (CARD) at the University of Central Florida (UCF).\r\nThis high-impact session will deliver critical information directly to families, caregivers, and professionals about Adia Med's ongoing clinical study (ClinicalTrials.gov ID: NCT07304440). The 24-month investigational trial is actively recruiting children ages 3–12 with Autism Spectrum Disorder (ASD) and is evaluating the potential of AdiaVita, umbilical cord blood-derived stem cells and exosomes, combined with glutathione—providing a safe, domestic, IRB-approved option right here in the United States.\r\nDr. Terri Daly, Ph.D., BCBA-D, Director of UCF CARD, recently shared the event on Facebook, highlighting strong early interest from the community and noting that the Zoom presentation offers a valuable opportunity for families to learn about Adia Med's domestic clinical research. This is particularly important for parents considering stem cell therapies, as it provides information about a U.S.-based study they may be able to enroll their child in, helping them make more informed decisions.\r\nWith tonight's presentation just hours away, this is a timely and powerful opportunity for families exploring regenerative approaches to connect directly with experts and learn about a credible U.S.-based clinical trial that prioritizes safety, transparency, and access to the investigational therapy for every enrolled child under close medical supervision.\r\n\"We're thrilled to collaborate with UCF CARD and Dr. Daly to bring this information straight to the families who need it most,\" said Larry Powalisz, CEO of Adia Nutrition. \"UCF CARD is not sponsoring this presentation or study in a...